Nanox Release
Likely to Engage tag.Highly Engaged Employees

Manufacturing · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

$6.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Nanox Release

Nanox is a nano-biotechnology company, constantly engaged in the research and development of advanced discovery, testing and commercialization of nano-pharmaceutical drugs. The company has developed and specialized in conventional liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations. These technologies are applicable to drugs, small molecules, peptides and proteins. Nanox's current activities have focused on the clinical development of nano-particulate targeting of drug to specific tissues with promise of progressive treatment and innovative therapeutics options with high efficacy and less side effects for patients with high unmet medical needs. As a fully integrated nanotechnology company, Nanox delivers innovative nanotech solutions, across discovery and development. The company's core business focuses in the development and innovation of alternative nanotech drug delivery processes and products destined to complex treRead more
Nanox Release's Social MediaPopular SearchesNanox ReleaseNanox Release Technology SASIC Code 28,283NAICS Code 32,325Show more

Nanox Release Org Chart

PhoneEmail
AP
United States flag for contact location.

Socio Fundador, Director De Operaciones

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MT
United States flag for contact location.

Project Manager

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Nanox Release your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Nanox Release is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Nanox Release is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nanox Release.

Nanox Release Tech Stack

A closer look at the technologies used by Nanox Release

Top Manufacturing Companies

Frequently Asked Questions Regarding Nanox Release

What is Nanox Release's official website?
Nanox Release's official website is www.nanoxrelease.com
What is Nanox Release's Revenue?
Nanox Release's revenue is $6.6 Million
What is Nanox Release's SIC code?
Nanox Release's SIC: 28,283
What is Nanox Release's NAICS code?
Nanox Release's NAICS: 32,325
How many employees does Nanox Release have?
Nanox Release has 11-50 employees
What industry does Nanox Release belong to?
Nanox Release is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Nanox Release use?
Some of the popular technologies that Nanox Release uses are: PHP 5.6, PHP, JQuery 1.11.1, Google Font API
What does Nanox Release do?

Nanox is a nano-biotechnology company, constantly engaged in the research and development of advanced discovery, testing and commercialization of nano-pharmaceutical drugs. The company has developed and specialized in conventional liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations.... These technologies are applicable to drugs, small molecules, peptides and proteins. Nanox's current activities have focused on the clinical development of nano-particulate targeting of drug to specific tissues with promise of progressive treatment and innovative therapeutics options with high efficacy and less side effects for patients with high unmet medical needs. As a fully integrated nanotechnology company, Nanox delivers innovative nanotech solutions, across discovery and development. The company's core business focuses in the development and innovation of alternative nanotech drug delivery processes and products destined to complex treatments such as oncology, hematology, transplants, infections and AIDS. In addition, Nanox provides advanced drug formulation, products development, clinical scale manufacturing and technical support to the pharmaceutical industry worldwide with a focus on difficult-to-formulate active pharmaceutical ingredients. We seek to deliver truly innovative and life-changing drugs. Our mission as a company is to build a major global nano-biopharmaceutical corporation while focusing on the discovery, the nano-technology, the development, and the commercialization of products for the treatment of the cancer and other severe immune, inflammatory conditions. Our Mission as a company is to build a major global nano-biopharmaceutical corporation while focusing on the discovery, the Nano- technology, the development, and the commercialization of products for the treatment of the cancer and other severe immune, inflammatory conditions. Liposomes are vesicular sacs similar to tiny cells, composed by durable lipid bilayer membranes that separate ...Read More

What are Nanox Release social media links?
Nanox Release Linkedin page
Is Nanox Release a public company?
Nanox Release is private company therefore does not currently have an official ticker symbol
See more information about Nanox Release

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.